Cargando…
Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19
We do not yet understand exactly how corticosteroids attenuate hyperinflammatory responses and alleviate high-risk coronavirus disease 2019 (COVID-19). We aimed to reveal the molecular mechanisms of hyperinflammation in COVID-19 and the anti-inflammatory effects of corticosteroids in patients with h...
Autores principales: | Jeong, Hyun-Woo, Lee, Jeong Seok, Ko, Jae-Hoon, Hong, Seunghee, Oh, Sang Taek, Choi, Seongkyun, Peck, Kyong Ran, Yang, Ji Hun, Chung, Seok, Kim, Sung-Han, Kim, Yeon-Sook, Shin, Eui-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026241/ https://www.ncbi.nlm.nih.gov/pubmed/36941461 http://dx.doi.org/10.1038/s12276-023-00964-8 |
Ejemplares similares
-
The type I interferon response in COVID-19: implications for treatment
por: Lee, Jeong Seok, et al.
Publicado: (2020) -
407 Impact of methicillin-resistance on mortality, hospital stay and medical cost in patients with Staphylococcus aureus bacteremia and endocarditis: A meta-analysis
por: Joo, Eun-Jeong, et al.
Publicado: (2014) -
The Efficacy of Corticosteroids in the Treatment of Peritonsillar Abscess: A Meta-Analysis
por: Lee, Yeon Ji, et al.
Publicado: (2016) -
Effect of short-term corticosteroid use on reactogenicity and immunogenicity of the first dose of ChAdOx1 nCoV-19 vaccine
por: Yang, Jinyoung, et al.
Publicado: (2021) -
Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine
por: Yang, Jinyoung, et al.
Publicado: (2021)